Ambalal Sarabhai Enterprises Ltd is in the business of manufacturing Pharmaceuticals and ElectronicsBusiness Overview: ASE is a pharmaceutical health care companies, which through its group companies, manufactures and markets pharmaceutical, molecular diagnostics, and electronics products in India and abroad
Ambalal Sarabhai Enterprises Limited has announced the publication of its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company confirmed these results were published in both English and Gujarati editions of the Western Times. This disclosure is a compliance update, offering stakeholders transparent access...
Ambalal Sarabhai Enterprises Limited has clarified the significant movement in its share price. The company stated it possesses no unpublished price sensitive information or undisclosed material events that could impact its securities. It confirmed that all necessary material information has been promptly shared with the Stock Exchange. The company emphasized...
Ambalal Sarabhai Enterprises (ASE) has announced a board meeting on August 12, 2026. Key agenda: approval of financial results for the quarter ended June 30, 2026. Trading window for shares remains closed until August 14.
We hereby submit Scrutinizer''s Report. Kindly take the same on your records.
We hereby submit outcome of the 48th Annual General Meeting. Kindly take the same on your records.
